Unique Online Radiation Therapy Course Inviting Participants
Targeting Cancer is delighted to feature alongside international experts in a forthcoming world-first online course aimed at the general community and those affected by cancer.
‘An Introduction to Radiation Oncology: From Diagnosis to Survivorship’ promotes the importance of modern radiation therapy in the management of many different cancers and the role of specialist healthcare teams delivering treatment and patient care.
Developed and run by Trinity College Dublin, Ireland’s highest-ranked university, and hosted on Futurelearn, the social learning platform, the free course features one of the ambassadors of RANZCR’s Targeting Cancer campaign, Julie McCrossin, in its teaching material.
Led by A/Prof Michelle Leech and A/Prof Claire Poole, radiation therapists from Trinity College Dublin, the course also features advocates from the International Atomic Energy Agency, the European Cancer Organisation, the Irish Cancer Society and Targeting Cancer.
Designed as a Massive Online Open Course (MOOC) and open to worldwide participants, it is expected to have a global reach to many thousands of people who might be unaware or have a poor understanding that radiation therapy is a highly effective and sophisticated cancer treatment.
“The course is a wonderful example of collaboration and resource-sharing for the benefit of cancer communities everywhere,” Targeting Cancer Clinical Lead A/Prof Sandra Turner, who also features in the module’s learning material, said. “Julie, myself and the Targeting Cancer team were delighted to be involved.
“The course is a wonderful example of collaboration and resource-sharing for the benefit of cancer communities everywhere.
“The invitation for Targeting Cancer to be involved in such a prestigious and vital project underlines the hugely significant work of radiation therapists, radiation oncologists, physicists and others involved in the campaign since its launch in October 2013.
“We thank Trinity College Dublin for inviting Targeting Cancer’s input into this critically important course, which will be of great value to patients, their families, the general community and health professionals worldwide.”
The course will start on September 3.
For more information on the course, including how to register, click here.